On sale for 125.00.   Or 2 for 220.00.   3 for 200.00

Reta is the common shorthand for retatrutide, an investigational once-weekly injectable drug developed by Eli Lilly.

It is a first-in-class triple hormone receptor agonist that activates GLP-1, GIP, and glucagon receptors at the same time. This multi-pathway action is designed to reduce appetite, improve insulin response, and increase energy expenditure/fat burning.

In clinical trials it has produced substantial average weight loss (around 24–28% of body weight at higher doses over 48–80 weeks in people with obesity), along with improvements in blood sugar and other metabolic markers. It is not yet FDA-approved and remains in late-stage (Phase 3) testing for obesity, type 2 diabetes, and related conditions.

100.00

MOTS-C is a naturally occurring mitochondrial peptide that is being researched for its potential to improve energy metabolism, insulin sensitivity, and exercise performance.

85.00. Or 2 for 150.00

TB-500 is a synthetic peptide derived from a portion of thymosin beta-4 that is being researched for its potential to support tissue repair, reduce inflammation, and promote healing.     65.00

60.00 or 2 for 100.00

GHK-Cu is a naturally occurring copper-binding peptide that is being researched for its potential to support skin repair, collagen production, wound healing, and hair growth. It is used in some cosmetic products, but injectable.    

60.00 or 2 for 100.00.

BPC-157 is a synthetic peptide that is being researched for its potential to support the healing of muscles, tendons, ligaments, and the digestive tract    

70.00 or 2 for 120.00

KPV (Lys-Pro-Val) is a synthetic tripeptide derived from alpha-melanocyte-stimulating hormone (α-MSH), commonly studied for its potent anti-inflammatory, antimicrobial, and tissue-repair properties. It is frequently researched for potential benefits in gut health, wound healing, and reducing systemic inflammation.